Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
RA Passerotto
Institution:
Università Cattolica del Sacro Cuore
Observed institution:
Università Cattolica del Sacro Cuore
ORCID:
0009-0007-4544-3373
Observed ORCID:
0009-0007-4544-3373
OpenAlex ID:
A5108326063
Effectiveness of bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) as switch strategy in virologically-suppressed patients: real world data from a monocentric cohort
2024
·
RA Passerotto
, F Lamanna
, et al.
·
Antiviral Therapy
·
7
SC-4 Risk of hepatitis B reactivation in people with HIV (PWH) with isolated anti-core antibody (HBcAb) after switch to 2DR strategies with Lamivudine (3TC)/dolutegravir (DTG)
2024
·
PF Salvo
, V Iannone
, et al.
·
Sexually Transmitted Infections
·
4
PDF
P-165 Association between emotional reactivity and internalized Stigma among People Living with HIV
2024
·
V Massaroni
, V Delle Donne
, et al.
·
Sexually Transmitted Infections
PDF
P-170 Sleep disorders in people living with HIV in integrase-inhibitors based regimen
2024
·
RA Passerotto
, D Farinacci
, et al.
·
Sexually Transmitted Infections
PDF
P-42 Fostemsavir plus doravirine for the treatment of heavily treatment-experienced (HTE) people with HIV (PWH) with multi-drug resistant (MDR) HIV-1 infection: 48 weeks results in a real-life setting
2024
·
PF Salvo
, V Iannone
, et al.
·
Sexually Transmitted Infections
PDF
Show more works
View as search
Works count:
5
Citation count:
11
H-index:
2
I10-index:
Year
Topic
Type